Goldman Sachs revealed the stocks most popular with the nearly $2 trillion hedge fund industry. The so-called VIP list has outperformed the S&P 500 this year.» Read More
He's a celebrated bear, so when Doug Kass of Seabreeze says the market has made it's low for the year, we listen.
The markets opened higher, but the Dow rally of 175 points was denied. But our traders see some positives in it all.
With a dividend increase and a 4% rally in the last month, can Caterpillar help you dig out of this market rut?
Does investor interest in BP mean you should establish a long position in the stock? Not necessarily. Scott Nations suggests the following options trade, instead.
Investors around the globe are closely watching the IPO of AgBank to determine if investor appetite for China is nearing a saturation point.
Predictions are skewing positive, so how should you game retail ahead of the all-important same-store sales figures coming later this week?
Following are the day’s biggest winners and losers. Find out why shares of Tenet Healthcare popped while Tesla and Office Depot dropped.
Investors can’t help but wonder just how relevant Microsoft will be in the future amid all their missteps.
One energy name gets an upgrade and the analyst who made the call explains why he likes this space.
A triple digit gain in the Dow couldn't ignite bullish sentiment on the Fast Money desk. The traders remained skeptical of Tuesday’s rally.
Here's our Fast Money Final Trade. Our gang gives you Tuesday's best trades, right now!
Not every trade works out. Especially Tim Seymour's long position in this stock!
Chatter that a major drug maker is looking to make at least one if not several acquisitions sent biotech surging. What must you know?
Chatter on Wall Street is all about how much farther stocks may fall. What seemed like just a correction at first is now starting to look like the start of a bear market.
Try to enjoy the holiday because Joe Terranova thinks Tuesday morning could be pretty nasty. Find out why he's bracing for a capitulation sell-off!
Which pharmaceutical company is reportedly preparing to spend $20 billion for a US drug maker?
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
The CEO of this company stopped by Fast Money to explain why the US and North America has the most potential for his business.
Should your book should be "Ford Tough"?
With crude prices lurching higher then bucking lower how should you game the energy space? Joe Terranova suggests the following!
Lee is host on CNBC's “Fast Money,” and “Options Action.”
Wapner is an award-winning reporter and the host of "Fast Money Halftime Report." He has also reported documentaries for CNBC.
Adami is a contributor on CNBC's "Fast Money." He is also Managing Director of stockMONSTER.com.
Najarian, the "Pit Boss," is cofounder of optionMONSTER.com, a news site for options traders.
Finerman is President of Metropolitan Capital Advisors, Inc., a company she co-founded.
Founder of EmergingMoney.com
Chief Market Strategist for Virtus Investment Partners & CNBC Contributor
Missed an episode of Fast Money? Watch the latest show here.
Sign up for our daily newsletter!
Download Fast Money onto your MP3 Player.